Artificial Intelligence as a Catalyst for Cell-Based Therapies in Retinal Disease

Girish K. Srivastava, Priyank Shukla, Sara Crespo Millas, Yogeswaran Lokanathan

Open source

DOI
10.3390/cells15201887
Published
2026-10-16
Container
Cells
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cells15201887,
  title = {Artificial Intelligence as a Catalyst for Cell-Based Therapies in Retinal Disease},
  author = {Girish K. Srivastava and Priyank Shukla and Sara Crespo Millas and Yogeswaran Lokanathan},
  year = {2026},
  journal = {Cells},
  doi = {10.3390/cells15201887},
  url = {https://doi.org/10.3390/cells15201887}
}

RIS

TY  - JOUR
TI  - Artificial Intelligence as a Catalyst for Cell-Based Therapies in Retinal Disease
AU  - Girish K. Srivastava
AU  - Priyank Shukla
AU  - Sara Crespo Millas
AU  - Yogeswaran Lokanathan
PY  - 2026
JO  - Cells
DO  - 10.3390/cells15201887
UR  - https://doi.org/10.3390/cells15201887
ER  - 

APA

Srivastava, G. K., Shukla, P., Millas, S. C., & Lokanathan, Y. (2026). Artificial Intelligence as a Catalyst for Cell-Based Therapies in Retinal Disease. Cells. https://doi.org/10.3390/cells15201887

Source records